Apogee Therapeutics
Cecilia Hale is a seasoned professional in the field of biostatistics, currently serving as Senior Director of Biostatistics at Apogee Therapeutics since March 2024. Prior experience includes holding the position of Senior Director of Biostatistics at Cara Therapeutics from May 2022 to January 2024 and Director roles at Alnylam Pharmaceuticals and Pfizer Consumer Healthcare. Cecilia has also contributed as VP of Biometrics at Hurley Consulting Associates and held various leadership positions at Progenics Pharmaceuticals and GlaxoSmithKline Consumer Healthcare. Cecilia's academic credentials include a PhD in Biostatistics from Columbia University and a BS in Mathematics from SUNY-Binghamton.
This person is not in any teams
This person is not in any offices